drugset / Trial / NCT00096304
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy, such as epirubicin and docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of epirubicin when given with docetaxel in treating patients with metastatic prostate cancer.
Timeline
- Start
- 2004-06-08
- Primary completion
- 2006-09-06
- Completion
- 2007-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epirubicin | Small molecule | — | — |
| Background | Docetaxel | Small molecule | — | — |